- Danaher plans to launch its first AI-powered autonomous lab in early 2027.
- The lab aims to deliver up to 8x faster discovery of affinity reagents.
- It aims to unlock up to a tenfold increase in annual reagent generation.
- The lab combines AI, robotics, and technologies from Beckman Coulter Life Sciences, Cytiva, Genedata, Integrated DNA Technologies, and Molecular Devices.
- The lab will be based at Abcam, a Danaher company.
- This is the first step in a broader Danaher initiative to create smart instruments, integrated workflows, and autonomous labs.
The headline and the read are open. The reasons are one free account away, on every story.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
BORSAPLUSWhy it matters · Bull and bear case · Reaction against SPY and the sector · What to watch
Create a free account · no card